Skip to main content
. Author manuscript; available in PMC: 2022 Oct 31.
Published in final edited form as: Dement Geriatr Cogn Disord. 2020 Jan 22;48(3-4):164–171. doi: 10.1159/000504801

Table 1:

Comparison of characteristics among respondents who did or did not developed severe cognitive impairment (CASI score <60) by exam 4.

SCI+ (n=189) SCI− (n=3,393)
Characteristic Mean (SD), % (#) Mean (SD), % (#) P value* OR (95% CI)
Age at exam 1, years 58.4 (5.4) 52.3 (4.4) <.0001 1.256 (1.22–1.29)
Education, years 8.0 (2.9) 10.6 (3.2) <.0001 0.731 (0.69–0.77)
Systolic blood pressure, mmHg 134.0 (21.4) 129.8 (18.3) .0094 1.011 (1.00–1.02)
Body mass index, kg/m2 23.8 (3.0) 23.9 (2.8) .7226 0.991 (0.94–1.04)
Cholesterol, mmol/L 5.6 (0.9) 5.7 (0.9) .5239 0.949 (0.81–1.12)
Physically active 92.1% (174) 82.6% (2,803) .0007 2.441 (1.43–4.17)
APOE ε4 carrier 19.6% (37) 18.4% (625) .6902 1.078 (0.75–1.56)
CAIDE score 9.49 (2.0) 7.21 (2.4) <.0001 1.477 (1.39–1.58)

Abbreviations: APOE ε4, apolipoprotein allele ε4; CASI, Cognitive Abilities Screening Instrument; CI, confidence interval; kg/m2, kilograms per meter squared; mmHg, millimeters of mercury; mmol/L, millimoles per liter; OR, odds ratio; SCI, severe cognitive impairment; SD, standard deviation.

NOTE: Bolding indentifies significant results.

*

P value for Satterthwaite t value or Pearson chi-square.

Odds ratio (OR) and 95% confidence interval (95% CI) for parameter estimate.